Breaking News Instant updates and real-time market news.

MGM

MGM Resorts

$43.12 /

+0.82 (+1.94%)

05:44
06/24/21
06/24
05:44
06/24/21
05:44

Deutsche upgrades MGM Resorts to Buy on margin upside potential

Deutsche Bank analyst Carlo Santarelli upgraded MGM Resorts to Buy from Hold with a price target of $54, up from $42. The "next leg of the stock story" is likely to be improving margins that extend well beyond the "over 30%" targets management has discussed as the Las Vegas Strip goal, as well as the 32.5% peak margins of 2006, Santarelli tells investors in a research note. The analyst sees out year consensus estimates for MGM as being too low and, accordingly, the perceived embedded sports / iCasino valuation as too high. As such, despite the strong performance in shares, he raised forecasts for MGM and upgraded the shares.

MGM MGM Resorts
$43.12 /

+0.82 (+1.94%)

06/24/21 Deutsche Bank
MGM Resorts upgraded to Buy from Hold at Deutsche Bank
06/10/21 JPMorgan
MGM Resorts price target raised to $52 from $47 at JPMorgan
05/18/21
Fly Intel: Top five analyst upgrades
05/18/21 JPMorgan
JPMorgan upgrades MGM after 11% selloff brings 'opportunity to buy'

TODAY'S FREE FLY STORIES

Earnings
Mercantile Bank reports Q3 EPS 95c, consensus 85c » 05:08
10/19/21
10/19
05:08
10/19/21
05:08
MBWM

Mercantile Bank

$33.77 /

-0.105 (-0.31%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MBWM Mercantile Bank
$33.77 /

-0.105 (-0.31%)

MBWM Mercantile Bank
$33.77 /

-0.105 (-0.31%)

Upgrade
SBA Communications upgraded to Outperform from Neutral at Credit Suisse » 05:07
10/19/21
10/19
05:07
10/19/21
05:07
SBAC

SBA Communications

$323.25 /

-3.505 (-1.07%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBAC SBA Communications
$323.25 /

-3.505 (-1.07%)

10/12/21 Wolfe Research
SBA Communications assumed with an Underperform at Wolfe Research
09/10/21 Morgan Stanley
SBA Communications price target raised to $405 from $337 at Morgan Stanley
08/19/21 Citi
SBA Communications price target raised to $404 from $343 at Citi
08/05/21 RBC Capital
SBA Communications price target raised to $370 from $335 at RBC Capital
SBAC SBA Communications
$323.25 /

-3.505 (-1.07%)

SBAC SBA Communications
$323.25 /

-3.505 (-1.07%)

Upgrade
Crown Castle upgraded to Outperform from Neutral at Credit Suisse » 05:06
10/19/21
10/19
05:06
10/19/21
05:06
CCI

Crown Castle

$167.81 /

-1.02 (-0.60%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CCI Crown Castle
$167.81 /

-1.02 (-0.60%)

CCI Crown Castle
$167.81 /

-1.02 (-0.60%)

10/12/21 Wolfe Research
Crown Castle assumed with an Underperform at Wolfe Research
09/30/21 JPMorgan
Crown Castle price target lowered to $200 from $210 at JPMorgan
09/10/21 Morgan Stanley
Crown Castle price target raised to $213 from $204 at Morgan Stanley
09/10/21 Oppenheimer
Crown Castle downgraded to Perform from Outperform at Oppenheimer
CCI Crown Castle
$167.81 /

-1.02 (-0.60%)

CCI Crown Castle
$167.81 /

-1.02 (-0.60%)

CCI Crown Castle
$167.81 /

-1.02 (-0.60%)

Earnings
Signature Bank reports Q3 EPS $3.88, consensus $3.72 » 05:05
10/19/21
10/19
05:05
10/19/21
05:05
SBNY

Signature Bank

$308.03 /

+2.37 (+0.78%)

Reports Q3 book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBNY Signature Bank
$308.03 /

+2.37 (+0.78%)

SBNY Signature Bank
$308.03 /

+2.37 (+0.78%)

10/07/21 Wells Fargo
Signature Bank price target raised to $390 from $345 at Wells Fargo
07/22/21 Credit Suisse
Signature Bank price target raised to $290 from $280 at Credit Suisse
07/21/21 Maxim
Signature Bank price target raised to $330 from $300 at Maxim
06/25/21 Piper Sandler
Signature Bank price target raised to $313 from $270 at Piper Sandler
SBNY Signature Bank
$308.03 /

+2.37 (+0.78%)

  • 21
    Jul
  • 05
    Feb
SBNY Signature Bank
$308.03 /

+2.37 (+0.78%)

Initiation
Alpha Cognition initiated with a Speculative Buy at Industrial Alliance » 05:05
10/19/21
10/19
05:05
10/19/21
05:05
ACOGF

Alpha Cognition

/

+

Industrial Alliance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACOGF Alpha Cognition
/

+

ACOGF Alpha Cognition
/

+

09/08/21 Raymond James
Alpha Cognition price target raised to C$3.50 from C$2.50 at Raymond James
Recommendations
Snap remains top pick in digital advertising at Piper Sandler » 04:59
10/19/21
10/19
04:59
10/19/21
04:59
SNAP

Snap

$75.79 /

-1.63 (-2.11%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNAP Snap
$75.79 /

-1.63 (-2.11%)

SNAP Snap
$75.79 /

-1.63 (-2.11%)

10/18/21 KeyBanc
KeyBanc ups Snap target to $90 ahead of Q3 results
10/18/21 BofA
Snap facing tougher comps in Q4, 1H22, says BofA
10/18/21 Wedbush
Wedbush continues to favor Google, Snap headed into quarterly results
10/05/21 Piper Sandler
Snap remained favorite app among teens in Piper's semi-annual survey
SNAP Snap
$75.79 /

-1.63 (-2.11%)

SNAP Snap
$75.79 /

-1.63 (-2.11%)

SNAP Snap
$75.79 /

-1.63 (-2.11%)

SNAP Snap
$75.79 /

-1.63 (-2.11%)

Initiation
Mandiant reinstated with a Neutral at Goldman Sachs » 04:57
10/19/21
10/19
04:57
10/19/21
04:57
MNDT

Mandiant

$18.40 /

+0.11 (+0.60%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNDT Mandiant
$18.40 /

+0.11 (+0.60%)

Initiation
Cue Health initiated with a Buy at Goldman Sachs » 04:56
10/19/21
10/19
04:56
10/19/21
04:56
HLTH

Cue Health

$10.01 /

-0.68 (-6.36%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HLTH Cue Health
$10.01 /

-0.68 (-6.36%)

  • 24
    Sep
HLTH Cue Health
$10.01 /

-0.68 (-6.36%)

HLTH Cue Health
$10.01 /

-0.68 (-6.36%)

Conference/Events
Motion Acquisition to hold a conference call » 04:55
10/19/21
10/19
04:55
10/19/21
04:55
MOTN

Motion Acquisition

$10.00 /

+ (+0.00%)

Group conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MOTN Motion Acquisition
$10.00 /

+ (+0.00%)

MOTN Motion Acquisition
$10.00 /

+ (+0.00%)

09/15/21 Northland
Motion Acquisition initiated with an Outperform at Northland
Conference/Events
Apollo Global to host virtual investor day » 04:55
10/19/21
10/19
04:55
10/19/21
04:55
APO

Apollo Global

$68.28 /

+0.865 (+1.28%)

Virtual Investor Day to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APO Apollo Global
$68.28 /

+0.865 (+1.28%)

APO Apollo Global
$68.28 /

+0.865 (+1.28%)

10/14/21 BMO Capital
JPMorgan price target raised to $140 from $139 at BMO Capital
09/16/21 Morgan Stanley
Reported offer to keep floor under Tronox's share price, says Morgan Stanley
08/05/21 Oppenheimer
Apollo Global price target raised to $67 from $62 at Oppenheimer
08/03/21 Morgan Stanley
Apollo Global, Nasdaq named Diversified Financials Top Picks at Morgan Stanley
APO Apollo Global
$68.28 /

+0.865 (+1.28%)

APO Apollo Global
$68.28 /

+0.865 (+1.28%)

APO Apollo Global
$68.28 /

+0.865 (+1.28%)

APO Apollo Global
$68.28 /

+0.865 (+1.28%)

Conference/Events
Benchmark building materials analyst to hold analyst/industry conference call » 04:55
10/19/21
10/19
04:55
10/19/21
04:55

Building Materials…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
NLS Pharmaceutics management to meet virtually with Maxim » 04:55
10/19/21
10/19
04:55
10/19/21
04:55
NLSP

NLS Pharmaceutics

$2.45 /

+ (+0.00%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NLSP NLS Pharmaceutics
$2.45 /

+ (+0.00%)

NLSP NLS Pharmaceutics
$2.45 /

+ (+0.00%)

03/12/21 Brookline
NLS Pharmaceutics initiated with a Buy at Brookline
03/03/21 Maxim
NLS Pharmaceutics initiated with a Buy at Maxim
  • 29
    Jan
Conference/Events
Ree Automotive management to meet virtually with BTIG » 04:55
10/19/21
10/19
04:55
10/19/21
04:55
REE

Ree Automotive

$4.22 /

+0.155 (+3.82%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REE Ree Automotive
$4.22 /

+0.155 (+3.82%)

REE Ree Automotive
$4.22 /

+0.155 (+3.82%)

09/13/21 Morgan Stanley
Ree Automotive initiated with an Underweight at Morgan Stanley
09/13/21 Morgan Stanley
Ree Automotive initiated with an Underweight at Morgan Stanley
08/18/21 BTIG
REE Automotive initiated with a Buy at BTIG
08/02/21 Cowen
REE Automotive initiated with an Outperform at Cowen
REE Ree Automotive
$4.22 /

+0.155 (+3.82%)

REE Ree Automotive
$4.22 /

+0.155 (+3.82%)

Conference/Events
Analog Devices management to meet with Truist » 04:55
10/19/21
10/19
04:55
10/19/21
04:55
ADI

Analog Devices

$173.37 /

+1.345 (+0.78%)

Small Group Meeting with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADI Analog Devices
$173.37 /

+1.345 (+0.78%)

ADI Analog Devices
$173.37 /

+1.345 (+0.78%)

10/13/21
Fly Intel: Top five analyst initiations
10/13/21 UBS
Analog Devices initiated with a Buy at UBS
10/07/21 Truist
Avnet price target lowered to $40 from $45 at Truist
09/20/21
Fly Intel: Top five analyst upgrades
ADI Analog Devices
$173.37 /

+1.345 (+0.78%)

ADI Analog Devices
$173.37 /

+1.345 (+0.78%)

ADI Analog Devices
$173.37 /

+1.345 (+0.78%)

ADI Analog Devices
$173.37 /

+1.345 (+0.78%)

Conference/Events
X4 Pharmaceuticals management to meet virtually with B. Riley » 04:55
10/19/21
10/19
04:55
10/19/21
04:55
XFOR

X4 Pharmaceuticals

$5.11 /

-0.11 (-2.11%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XFOR X4 Pharmaceuticals
$5.11 /

-0.11 (-2.11%)

XFOR X4 Pharmaceuticals
$5.11 /

-0.11 (-2.11%)

06/11/21 Roth Capital
X4 Pharmaceuticals price target raised to $27 from $23 at Roth Capital
12/17/20 Brookline
X4 Pharmaceuticals initiated with a Buy at Brookline
12/14/20 Roth Capital
New CMO 'another solid addition' to X4 Pharmaceuticals team, says Roth Capital
XFOR X4 Pharmaceuticals
$5.11 /

-0.11 (-2.11%)

XFOR X4 Pharmaceuticals
$5.11 /

-0.11 (-2.11%)

Conference/Events
Arbe Robotics management to meet virtually with Roth Capital » 04:55
10/19/21
10/19
04:55
10/19/21
04:55
ARBE

Arbe Robotics

$8.21 /

-0.32 (-3.75%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARBE Arbe Robotics
$8.21 /

-0.32 (-3.75%)

10/15/21
Fly Intel: Top five analyst initiations
10/15/21 Roth Capital
Arbe Robotics initiated with a Buy at Roth Capital
10/14/21 R.F. Lafferty
Arbe Robotics initiated with a Buy at R.F. Lafferty
Conference/Events
Credit Suisse to hold a virtual conference » 04:55
10/19/21
10/19
04:55
10/19/21
04:55

10th Annual Brazil Real…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
BridgeBio participates in a conference call with Jefferies » 04:55
10/19/21
10/19
04:55
10/19/21
04:55
BBIO

BridgeBio

$47.85 /

-0.14 (-0.29%)

Jefferies Healthcare…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBIO BridgeBio
$47.85 /

-0.14 (-0.29%)

BBIO BridgeBio
$47.85 /

-0.14 (-0.29%)

09/10/21 BofA
BridgeBio upgraded to Buy from Neutral at BofA
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/13/21 Oppenheimer
Prothena price target raised to $76 from $54 at Oppenheimer
05/20/21 UBS
BridgeBio initiated with a Buy at UBS
BBIO BridgeBio
$47.85 /

-0.14 (-0.29%)

  • 12
    Feb
Conference/Events
JPMorgan LatAm commodities analysts hold analyst/industry conference call » 04:55
10/19/21
10/19
04:55
10/19/21
04:55

LatAm Commodities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Ulta Beauty to hold virtual analyst day » 04:55
10/19/21
10/19
04:55
10/19/21
04:55
ULTA

Ulta Beauty

$406.23 /

+0.68 (+0.17%)

Virtual Analyst Day to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$406.23 /

+0.68 (+0.17%)

ULTA Ulta Beauty
$406.23 /

+0.68 (+0.17%)

10/14/21 Deutsche Bank
Ulta Beauty price target raised to $483 from $478 at Deutsche Bank
10/08/21 Cleveland Research
Ulta Beauty upgraded to Buy from Neutral at Cleveland Research
10/05/21 Piper Sandler
Piper teen survey shows clothing outranked food for first time since 2014
08/27/21
Fly Intel: Top five analyst downgrades
ULTA Ulta Beauty
$406.23 /

+0.68 (+0.17%)

ULTA Ulta Beauty
$406.23 /

+0.68 (+0.17%)

ULTA Ulta Beauty
$406.23 /

+0.68 (+0.17%)

ULTA Ulta Beauty
$406.23 /

+0.68 (+0.17%)

Conference/Events
In8bio management to meet virtually with B. Riley » 04:55
10/19/21
10/19
04:55
10/19/21
04:55
INAB

In8bio

$5.79 /

-0.16 (-2.69%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INAB In8bio
$5.79 /

-0.16 (-2.69%)

INAB In8bio
$5.79 /

-0.16 (-2.69%)

08/24/21 Mizuho
In8bio initiated with a Buy at Mizuho
08/23/21 B. Riley
In8bio initiated with a Buy on cancer potential at B. Riley
08/23/21 B. Riley
In8bio initiated with a Buy at B. Riley
  • 30
    Jul
  • 13
    Nov
INAB In8bio
$5.79 /

-0.16 (-2.69%)

Conference/Events
Milken Institute to hold a conference » 04:55
10/19/21
10/19
04:55
10/19/21
04:55

Milken Institute Global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call » 04:55
10/19/21
10/19
04:55
10/19/21
04:55
SNY

Sanofi

$48.04 /

-0.805 (-1.65%)

, FOLD

Amicus

$10.70 /

-0.4 (-3.60%)

, ABEO

Abeona Therapeutics

/

+

, QURE

uniQure

$28.30 /

-1.74 (-5.79%)

, SIOX

Sio Gene Therapies

$2.18 /

+0.01 (+0.46%)

, TSHA

Taysha Gene Therapies

$17.07 /

-1.08 (-5.95%)

, SELB

Selecta Biosciences

$4.11 /

-0.16 (-3.75%)

, DNLI

Denali Therapeutics

$45.18 /

-0.39 (-0.86%)

, ORTX

Orchard Therapeutics

$2.12 /

-0.06 (-2.75%)

Biotech Analysts Duncan,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$48.04 /

-0.805 (-1.65%)

FOLD Amicus
$10.70 /

-0.4 (-3.60%)

ABEO Abeona Therapeutics
/

+

QURE uniQure
$28.30 /

-1.74 (-5.79%)

SIOX Sio Gene Therapies
$2.18 /

+0.01 (+0.46%)

TSHA Taysha Gene Therapies
$17.07 /

-1.08 (-5.95%)

SELB Selecta Biosciences
$4.11 /

-0.16 (-3.75%)

DNLI Denali Therapeutics
$45.18 /

-0.39 (-0.86%)

ORTX Orchard Therapeutics
$2.12 /

-0.06 (-2.75%)

SNY Sanofi
$48.04 /

-0.805 (-1.65%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
FOLD Amicus
$10.70 /

-0.4 (-3.60%)

09/30/21
Fly Intel: Top five analyst upgrades
09/30/21 Cowen
Amicus spin-out and profit potential makes it takeout target, says Cowen
09/30/21 JPMorgan
Amicus upgraded to Overweight from Neutral at JPMorgan
07/19/21 BTIG
Amicus assumed with a Buy at BTIG
ABEO Abeona Therapeutics
/

+

07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
11/25/20 H.C. Wainwright
Abeona Therapeutics price target lowered to $8 from $11 at H.C. Wainwright
11/11/20 B. Riley Securities
Abeona Therapeutics price target raised to $3 from $2 at B. Riley Securities
11/10/20 Cantor Fitzgerald
Cantor upgrades Abeona to Overweight with shares trading near cash
QURE uniQure
$28.30 /

-1.74 (-5.79%)

07/27/21 Chardan
uniQure price target lowered to $95 from $100 at Chardan
07/09/21 Chardan
uniQure coverage transferred at Chardan
06/23/21 Chardan
uniQure filing delay could yield better label for EtranaDez, says Chardan
06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
SIOX Sio Gene Therapies
$2.18 /

+0.01 (+0.46%)

07/09/21 Chardan
Sio Gene Therapies coverage transferred at Chardan
06/14/21 BTIG
Sio Gene Therapies initiated with a Buy at BTIG
04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
TSHA Taysha Gene Therapies
$17.07 /

-1.08 (-5.95%)

10/05/21 Needham
Taysha Gene Therapies price target raised to $47 from $45 at Needham
08/17/21 Chardan
Taysha Gene Therapies price target lowered to $60 from $67.50 at Chardan
07/15/21 Needham
Taysha Gene Therapies initiated with a Buy at Needham
07/09/21 Chardan
Taysha Gene Therapies coverage transferred at Chardan
SELB Selecta Biosciences
$4.11 /

-0.16 (-3.75%)

07/22/21 Cantor Fitzgerald
Incorrect headline could be cause of Selecta weakness, says Cantor Fitzgerald
06/14/21 BTIG
Selecta Biosciences initiated with a Buy at BTIG
04/29/21 Mizuho
Mizuho sees 'minimal impact' to Selecta Biosciences from AskBio assumption news
03/12/21 William Blair
Selecta upgraded to Outperform ahead of catalysts at William Blair
DNLI Denali Therapeutics
$45.18 /

-0.39 (-0.86%)

09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
09/01/21 SMBC Nikko
Denali Therapeutics initiated with an Outperform at SMBC Nikko
07/26/21 Stifel
Denali DNL310 data 'noisy and trending in wrong direction,' says Stifel
07/26/21 H.C. Wainwright
Denali Therapeutics price target raised to $105 from $95 at H.C. Wainwright
ORTX Orchard Therapeutics
$2.12 /

-0.06 (-2.75%)

08/18/21 JPMorgan
Orchard Therapeutics downgraded to Neutral from Overweight at JPMorgan
07/02/21 Wedbush
Pharming collaboration offers upside for Orchard Therapeutics, says Wedbush
06/30/21 JPMorgan
Orchard Therapeutics price target lowered to $14 from $15 at JPMorgan
06/30/21 Cantor Fitzgerald
Orchard Therapeutics price target lowered to $12 from $17 at Cantor Fitzgerald
SNY Sanofi
$48.04 /

-0.805 (-1.65%)

FOLD Amicus
$10.70 /

-0.4 (-3.60%)

ABEO Abeona Therapeutics
/

+

QURE uniQure
$28.30 /

-1.74 (-5.79%)

SIOX Sio Gene Therapies
$2.18 /

+0.01 (+0.46%)

TSHA Taysha Gene Therapies
$17.07 /

-1.08 (-5.95%)

SELB Selecta Biosciences
$4.11 /

-0.16 (-3.75%)

DNLI Denali Therapeutics
$45.18 /

-0.39 (-0.86%)

ORTX Orchard Therapeutics
$2.12 /

-0.06 (-2.75%)

SNY Sanofi
$48.04 /

-0.805 (-1.65%)

ORTX Orchard Therapeutics
$2.12 /

-0.06 (-2.75%)

SNY Sanofi
$48.04 /

-0.805 (-1.65%)

FOLD Amicus
$10.70 /

-0.4 (-3.60%)

QURE uniQure
$28.30 /

-1.74 (-5.79%)

TSHA Taysha Gene Therapies
$17.07 /

-1.08 (-5.95%)

DNLI Denali Therapeutics
$45.18 /

-0.39 (-0.86%)

Conference/Events
Smartsheet management to meet virtually with KeyBanc » 04:55
10/19/21
10/19
04:55
10/19/21
04:55
SMAR

Smartsheet

$69.56 /

-0.185 (-0.27%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMAR Smartsheet
$69.56 /

-0.185 (-0.27%)

SMAR Smartsheet
$69.56 /

-0.185 (-0.27%)

09/08/21 BMO Capital
Smartsheet price target raised to $90 from $78 at BMO Capital
09/08/21 Truist
Smartsheet price target raised to $100 from $85 at Truist
09/08/21 Needham
Smartsheet price target raised to $100 from $80 at Needham
09/08/21 KeyBanc
Smartsheet price target raised to $94 from $86 at KeyBanc
SMAR Smartsheet
$69.56 /

-0.185 (-0.27%)

SMAR Smartsheet
$69.56 /

-0.185 (-0.27%)

SMAR Smartsheet
$69.56 /

-0.185 (-0.27%)

Initiation
Clearwater Analytics initiated with a Neutral at Goldman Sachs » 04:54
10/19/21
10/19
04:54
10/19/21
04:54
CWAN

Clearwater Analytics

$25.19 /

+0.78 (+3.20%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 24
    Sep
CWAN Clearwater Analytics
$25.19 /

+0.78 (+3.20%)

CWAN Clearwater Analytics
$25.19 /

+0.78 (+3.20%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.